July 1, 2006

New Leukemia Drug Approved

U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).

The drug, Sprycel (generic name dasatinib), was also given regular approval to treat adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), a more serious form of leukemia. (excite.com)

Talk about this story

Remember Me?

Related Stories

More News Topics:
Breast Cancer      Alternative Medicine      Infectious Disease       Eating Disorders       Sleep      Orthopedic      Allergies      Neurological Disorders      Chronic Pain       Senior Health       Heart Health      Mental Health       Autoimmune Disorders       Women's Health
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your health routine or treatment.

Copyright © 2004-2005 HealthDiaries.com. All rights reserved.